AMLX Stock: Price, Earnings History and SEC Filings
Amylyx Pharmaceuticals, Inc. (AMLX) last traded at $28.86, up 0.63% on the latest session and down 0.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.39 against an analyst estimate of $-0.36, a miss of 8.3%.
$28.86 +0.63%
1 month-0.82%
52-week high$41.14
52-week low$10.83
Volume774,154
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AMLX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.39 | $-0.36 | -8.33% |
| Mar 2026 | May 7, 2026 | $-0.37 | $-0.34 | -8.82% |
| Dec 2025 | Mar 3, 2026 | $-0.30 | $-0.31 | +3.23% |
| Sep 2025 | Nov 6, 2025 | $-0.37 | $-0.43 | +13.95% |
AMLX beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AMLX
SEC filing data is not available right now. You can search for AMLX on SEC EDGAR.
AMLX news
- Can Corcept Therapeutics Stock Rally 40% After This Dip?Oct 26, 2026 · trefis.com
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) is a US-listed public company on Nasdaq.